 |
Uduak Grace Thomas is the editor of GenomeWeb's BioInform. She covers bioinformatics, computational biology, and life science informatics. E-mail Uduak Grace Thomas or follow her GenomeWeb Twitter account at @BioInformGW. |
Accelrys Sees 14 Percent Growth in Q2 Revenues Despite Decline in Overseas Sales
August 03, 2012
Accelrys Sees 14 Percent Growth in Q2 Revenues Despite Decline in Overseas Sales
Full-text access for premium subscribers only.
Existing premium subscribers login here.
New to GenomeWeb? Register here quickly.
New to GenomeWeb? Register here quickly.
Related Stories
- Accelrys' Q1 Revenues Rise 7 Percent but Fall Short of Estimates
May 1, 2013 / GenomeWeb Daily News - Accelrys Posts 11 Percent Revenue Gain for Q4
February 26, 2013 / GenomeWeb Daily News - Downloads and Upgrades: PubmiR, Cytoscape 3.0, DNAnexus, and more.
February 8, 2013 / BioInform - Accelrys Buys Vialis for up to $10 Million
January 17, 2013 / GenomeWeb Daily News - New Players, Clinical Applications, and the Lure of Commercialization among 2012 Bioinformatics Trends
January 4, 2013 / BioInform